CRISPR-based platforms such as SHERLOCK and DETECTR enable point-of-care testing, multiplexed detection, and portable diagnostics, transforming healthcare delivery in resource-limited settings.
This test is ... is a Houston-based molecular diagnostic solutions provider founded in July 2022. The mission is to advance disease detection and treatment by commercializing the CRISPR detection ...
HOUSTON, Jan. 21, 2025 /PRNewswire/ -- IntelliGenome, an innovative molecular diagnostic solutions provider, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback